https://orcid.org/0000-0002-2047-5025
References
- Borges AF, Silva C, Coelho JF, Simões S. (2015). Oral films: Current status and future perspectives: I - Galenical development and quality attributes. J Control Release. 206:1–19.
- Brniak W, Maślak E, Jachowicz R. (2015). Orodispersible films and tablets with prednisolone microparticles. Eur J Pharm Sci 75:81–90.
- Core Team. (2013). R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available at: http://www.R-project.org/.
- EMA. 2013. Guideline on pharmaceutical development of medicines for paediatric use EMA/CHMP/QWP/805880/2012. London. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/07/WC500147002.pdf (last accessed May 2017).
- Hoffmann EM, Breitenbach A, Breitkreutz J. (2011). Advances in orodispersible films for drug delivery. Expert Opin Drug Deliv 8:299–316.
- Kozarewicz P. (2014). Regulatory perspectives on acceptability testing of dosage forms in children. Int J Pharm 469:245–8.
- Kraus DM, Stohlmeyer LA, Hannon PR. (1999). Infant acceptance and effectiveness of a new oral liquid medication delivery system. Am J Health Syst Pharm 56:1094–101.
- Matza LS, Patrick D, Riley AW, et al. (2013). Pediatric patient-reported outcome instruments for research to support medical product labeling: Report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. Value Health 16:461–79.
- McGraw KO, Wong SP. (1996). Forming inferences about some intraclass correlation coefficients. Psychological Methods 1:30–46.
- medicines.org.uk. 2017. Home: electronic Medicines Compendium (eMC). Available at: https://www.medicines.org.uk/emc/medicine/28019 [last accessed May 2017].
- Mistry P, Batchelor H. (2017). Evidence of acceptability of oral paediatric medicines: a review. J Pharm Pharmacol 69:361–76.
- Preis M, Woertz C, Kleinebudde P, Breitkreutz J. (2013). Oromucosal film preparations: classification and characterization methods . Expert Opin Drug Deliv 10:1303–17.
- Rodd C, Jean-Philippe S, Vanstone C, Weiler H. (2011). Comparison of 2 vitamin D supplementation modalities in newborns: adherence and preference. Appl Physiol Nutr Metab 36:414–8.
- Sayinsu K, Isik F, Trakyali G, Arun T. (2007). An evaluation of the errors in cephalometric measurements on scanned cephalometric images and conventional tracings. Eur J Orthod 29:105–8.
- Slavkova M, Breitkreutz J. (2015). Orodispersible drug formulations for children and elderly. Eur J Pharm Sci 75:2–9.
- Thompson SA, Tuleu C, Wong ICK, et al. (2009). Minitablets: new modality to deliver medicines to preschool-aged children. Pediatrics 123: e235–8.
- van Riet-Nales D, Schobben AFAM, Vromans H, et al. (2016). Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects. Arch Dis Child 101: 662–9.
- Visser JC, Dohmen WM, Hinrichs WL, et al. (2015a). Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films. Int J Pharm 485:70–6.
- Visser JC, Woerdenbag HJ, Crediet S, et al. (2015b). Orodispersible films in individualized pharmacotherapy: the development of a formulation for pharmacy preparations. Int J Pharm 478:155–63.